Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (980)

411

Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial

in: Trials | 2021

von Alonso Soto | Fiorella Krapp | Alex Vargas | +7

412

The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial

in: Trials | 2021

von A. Guillen-Sola | M. Messaggi-Sartor | C. Ramírez-Fuentes | +2

413

Primary Care implementation of Germ Defence, a digital behaviour change intervention to improve household infection control during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Jeremy Horwood | Melanie Chalder | Ben Ainsworth | +19

414

A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Murat Akova | Serhat Unal

415

A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial

in: Trials | 2021

von Natalie L. McEvoy | Jennifer L. Clarke | Oliver J. Mc Elvaney | +14

416

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal

in: Trials | 2021

von Dana N. Raugi | Khardiata Diallo | Mouhamadou Baïla Diallo | +14

417

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Eleonora Aricò | Luciano Castiello | Laura Bracci | +16

418

Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov

in: Trials | 2021

von Kentaro Sakamaki | Yukari Uemura | Yosuke Shimizu

419

Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2021

von Petri J. Vainio | Pauliina Hietasalo | Anna-Liisa Koivisto | +5

420

Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial

in: Trials | 2021

von Philippe Bégin | Jeannie Callum | Nancy M. Heddle | +37